Localisation of sentinel lymph nodes in patients with melanomas by planar lymphoscintigraphic and hybrid SPECT/CT imaging
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F12%3A00102568" target="_blank" >RIV/00843989:_____/12:00102568 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/61988987:17110/12:A13016PR
Výsledek na webu
<a href="http://dx.doi.org/10.5603/NMR.2012.0003" target="_blank" >http://dx.doi.org/10.5603/NMR.2012.0003</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5603/NMR.2012.0003" target="_blank" >10.5603/NMR.2012.0003</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Localisation of sentinel lymph nodes in patients with melanomas by planar lymphoscintigraphic and hybrid SPECT/CT imaging
Popis výsledku v původním jazyce
The aim of the study was to assess the role of planar lymphoscintigraphy and fusion imaging of SPECT/CT in sentinel lymph node (SLN) identification in patients with melanomas. Planar and hybrid SPECT/low-dose CT lymphoscintigraphy were performed in 113 consecutive patients with melanomas (59 men, 54 women, mean age 57.6 with range 11?87 years, BMI 29.4 12.5). The radiopharmaceutical was injected around the tumour (Group A, 59 patients), or around the scar (Group B, 54 patients). Localisation of melanomas: head and neck 4, trunk 55, upper extremities 28, lower extremities 26. Planar and SPECT/CT images were interpreted separately by two nuclear medicine physicians. Abilities of these two techniques to image SLN were compared. SLNs were detected on lymphoscintigraphy comprising planar and SPECT-CT images in 108 (95.6%) study patients; there was failure to detect SLNs in the remaining 5 (4.4%) patients. Planar images identified 253 SLNs in 100 (88.5%) pts, with a mean of 2.2 1.7 (range 0?
Název v anglickém jazyce
Localisation of sentinel lymph nodes in patients with melanomas by planar lymphoscintigraphic and hybrid SPECT/CT imaging
Popis výsledku anglicky
The aim of the study was to assess the role of planar lymphoscintigraphy and fusion imaging of SPECT/CT in sentinel lymph node (SLN) identification in patients with melanomas. Planar and hybrid SPECT/low-dose CT lymphoscintigraphy were performed in 113 consecutive patients with melanomas (59 men, 54 women, mean age 57.6 with range 11?87 years, BMI 29.4 12.5). The radiopharmaceutical was injected around the tumour (Group A, 59 patients), or around the scar (Group B, 54 patients). Localisation of melanomas: head and neck 4, trunk 55, upper extremities 28, lower extremities 26. Planar and SPECT/CT images were interpreted separately by two nuclear medicine physicians. Abilities of these two techniques to image SLN were compared. SLNs were detected on lymphoscintigraphy comprising planar and SPECT-CT images in 108 (95.6%) study patients; there was failure to detect SLNs in the remaining 5 (4.4%) patients. Planar images identified 253 SLNs in 100 (88.5%) pts, with a mean of 2.2 1.7 (range 0?
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FP - Ostatní lékařské obory
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2012
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Nuclear medicine review
ISSN
1506-9680
e-ISSN
—
Svazek periodika
15
Číslo periodika v rámci svazku
2
Stát vydavatele periodika
PL - Polská republika
Počet stran výsledku
7
Strana od-do
101-107
Kód UT WoS článku
—
EID výsledku v databázi Scopus
—